Candriam SCA’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-222,000
| Closed | -$4.16M | – | 723 |
|
|
2024
Q1 | $4.16M | Sell |
222,000
-5,000
| -2% | -$93.7K | 0.03% | 372 |
|
|
2023
Q4 | $4.92M | Hold |
227,000
| – | – | 0.03% | 336 |
|
|
2023
Q3 | $4.67M | Hold |
227,000
| – | – | 0.03% | 314 |
|
|
2023
Q2 | $10.7M | Buy |
227,000
+137,000
| +152% | +$6.44M | 0.08% | 237 |
|
|
2023
Q1 | $3.48M | Buy |
+90,000
| New | +$3.48M | 0.02% | 451 |
|
|
2021
Q4 | – | Sell |
-185,058
| Closed | -$8.2M | – | 855 |
|
|
2021
Q3 | $8.2M | Buy |
185,058
+46,490
| +34% | +$2.06M | 0.06% | 309 |
|
|
2021
Q2 | $7.87M | Sell |
138,568
-6,079
| -4% | -$345K | 0.05% | 323 |
|
|
2021
Q1 | $12M | Hold |
144,647
| – | – | 0.1% | 222 |
|
|
2020
Q4 | $12.5M | Sell |
144,647
-4,653
| -3% | -$403K | 0.1% | 226 |
|
|
2020
Q3 | $9.13M | Buy |
+149,300
| New | +$9.13M | 0.09% | 252 |
|
|
2020
Q2 | – | Sell |
-149,300
| Closed | -$10.5M | – | 330 |
|
|
2020
Q1 | $10.5M | Hold |
149,300
| – | – | 0.12% | 203 |
|
|
2019
Q4 | $10.8M | Buy |
149,300
+10,000
| +7% | +$722K | 0.12% | 205 |
|
|
2019
Q3 | $19.5M | Buy |
139,300
+21,000
| +18% | +$2.95M | 0.26% | 76 |
|
|
2019
Q2 | $21.6M | Sell |
118,300
-60,000
| -34% | -$10.9M | 0.27% | 80 |
|
|
2019
Q1 | $28.4M | Buy |
178,300
+18,000
| +11% | +$2.86M | 0.36% | 52 |
|
|
2018
Q4 | $15.4M | Buy |
160,300
+22,500
| +16% | +$2.16M | 0.24% | 100 |
|
|
2018
Q3 | $19.5M | Buy |
137,800
+81,400
| +144% | +$11.5M | 0.26% | 92 |
|
|
2018
Q2 | $8.83M | Buy |
56,400
+18,400
| +48% | +$2.88M | 0.14% | 189 |
|
|
2018
Q1 | $6.12M | Hold |
38,000
| – | – | 0.1% | 247 |
|
|
2017
Q4 | $6.26M | Sell |
38,000
-16,000
| -30% | -$2.64M | 0.11% | 226 |
|
|
2017
Q3 | $3.36M | Sell |
54,000
-9,000
| -14% | -$561K | 0.06% | 351 |
|
|
2017
Q2 | $5.02M | Sell |
63,000
-10,000
| -14% | -$797K | 0.09% | 261 |
|
|
2017
Q1 | $5.19M | Buy |
73,000
+41,000
| +128% | +$2.91M | 0.1% | 244 |
|
|
2016
Q4 | $1.63M | Sell |
32,000
-7,000
| -18% | -$357K | 0.04% | 406 |
|
|
2016
Q3 | $1.8M | Sell |
39,000
-35,000
| -47% | -$1.61M | 0.04% | 378 |
|
|
2016
Q2 | $2.23M | Buy |
74,000
+5,000
| +7% | +$151K | 0.06% | 291 |
|
|
2016
Q1 | $2.2M | Sell |
69,000
-7,200
| -9% | -$230K | 0.06% | 308 |
|
|
2015
Q4 | $4.44M | Buy |
76,200
+10,000
| +15% | +$583K | 0.12% | 195 |
|
|
2015
Q3 | $2.8M | Sell |
66,200
-5,800
| -8% | -$245K | 0.07% | 297 |
|
|
2015
Q2 | $5.26M | Sell |
72,000
-7,000
| -9% | -$511K | 0.11% | 233 |
|
|
2015
Q1 | $3.97M | Buy |
79,000
+14,000
| +22% | +$703K | 0.08% | 291 |
|
|
2014
Q4 | $2.38M | Buy |
+65,000
| New | +$2.38M | 0.05% | 336 |
|